Ardent Health Partners, LLC (NYSE:ARDT) Receives Consensus Rating of "Buy" from Analysts

Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) has received a consensus rating of "Buy" from the twelve analysts that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $21.36.

A number of research firms have commented on ARDT. Stephens restated an "overweight" rating and issued a $22.00 price target on shares of Ardent Health Partners in a research report on Thursday. Leerink Partners boosted their target price on Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a report on Tuesday, November 12th. Bank of America cut Ardent Health Partners from a "buy" rating to a "neutral" rating and dropped their price target for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Finally, Truist Financial lowered their target price on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Monday, January 6th.

Ardent Health Partners Price Performance

Shares of ARDT traded up $0.38 during mid-day trading on Friday, reaching $15.04. The company had a trading volume of 838,433 shares, compared to its average volume of 406,064. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a twelve month low of $13.55 and a twelve month high of $20.72. The company's 50-day moving average is $15.20 and its 200-day moving average is $16.84.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. On average, research analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Hedge Funds Weigh In On Ardent Health Partners

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Ardent Health Partners in the 4th quarter valued at $27,000. US Bancorp DE acquired a new position in Ardent Health Partners in the fourth quarter valued at about $31,000. R Squared Ltd bought a new position in Ardent Health Partners during the fourth quarter worth about $37,000. BNP Paribas Financial Markets acquired a new position in shares of Ardent Health Partners during the 3rd quarter worth about $42,000. Finally, New York State Common Retirement Fund bought a new stake in shares of Ardent Health Partners in the 4th quarter valued at about $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.